A peptide experiment can produce a perfect graph and still be scientifically weak.
Why? Because a graph only shows the final picture. It does not explain where the peptide came from, how it was stored, who prepared it, what happened during the assay, or why one sample was tested twice.
Think of laboratory documentation as a bridge. Your experiment stands on one side, while your conclusion stands on the other. When important records are missing, that bridge develops gaps. You may still cross it once, but another researcher may not be able to follow you.
Good documentation helps a research team reconstruct an experiment from beginning to end. It also helps identify mistakes, compare batches, train new staff, prepare publications, protect intellectual property, and respond to questions from reviewers or regulators.
The National Institutes of Health treats rigorous design, transparent reporting, and reproducibility as central parts of reliable biomedical research. In 2026, NIH also strengthened its focus on replication and reproducibility across funded research.
This guide explains how to create clear, useful, and trustworthy records for peptide experiments without turning the laboratory notebook into a pile of paperwork.
Why Peptide Documentation Needs Special Attention
Peptides may appear simple because they are smaller than many proteins. In practice, they can be sensitive experimental materials.
A peptide result may change because of its amino acid sequence, modification, purity, counterion, solvent, concentration, container, storage time, temperature, light exposure, repeated freezing, or contact with a biological matrix.
Some peptides can also attach to container surfaces. This is called nonspecific adsorption. When it happens, the amount of peptide available for measurement may fall, especially at low concentrations. A study on peptide analysis by UPLC and mass spectrometry showed that nonspecific adsorption can negatively affect analytical results and should be evaluated during method development.
This is why writing only “peptide added to cells” is not enough. Which peptide was added? Which batch? At what true concentration? In which solvent? How long had it been in solution? Which tube was used?
A complete record answers these questions before anyone needs to ask them.
1. Begin With a Clear Experimental Question
Documentation should begin before the peptide leaves the freezer.
Write the main question in simple language. For example:
“Does peptide P17 reduce the inflammatory response in treated human cell cultures?”
Next, record the hypothesis, the primary outcome, the experimental groups, the controls, and the planned analysis.
This short planning step prevents a common problem. Researchers sometimes collect many measurements and later choose the result that looks most interesting. A written plan creates a clear line between the original question and later exploratory findings.
Your initial record should contain:
- The experiment identification code
- The project title
- The research question
- The hypothesis
- The primary outcome
- The secondary outcomes
- The treatment groups
- The control groups
- The planned number of samples
- The planned statistical method
- The name of the researcher
- The planned start and completion dates
Scientific rigor involves applying suitable methods to experimental design, data collection, analysis, interpretation, and reporting. NIH guidance places particular attention on unbiased design and transparent reporting.
2. Create a Complete Peptide Identity Record
The peptide identity record acts like a passport. It should travel with the material through every experiment.
Record the full amino acid sequence exactly as supplied. Do not depend only on an informal name such as “test peptide 2.” Two peptides may have similar names but different sequences, terminal groups, labels, or modifications.
Include the following information:
- Peptide name and internal code
- Full amino acid sequence
- Sequence direction
- Molecular formula, when available
- Expected molecular mass
- Terminal modifications
- Side chain modifications
- Labels or conjugates
- Disulfide bond information
- Salt or counterion form
- Supplier or synthesis facility
- Catalogue number
- Batch or lot number
- Date received
- Certificate of analysis location
- Reported purity
- Method used to assess purity
- Net peptide content, when provided
- Expiry or retest date
- Intended research use
Purity needs careful wording. An area percentage from a chromatogram is not always equal to the actual mass fraction of peptide in a vial. NIST reference material records show that chromatographic area purity, peptide mass purity, sequence identity, and measured molecular mass are separate pieces of information.
For that reason, do not record only “95 percent pure.” Write what the percentage means and how it was measured.
3. Save the Original Supplier Documents
Store the certificate of analysis, product sheet, safety information, shipping record, and any custom synthesis report.
The certificate of analysis may contain details that are easy to overlook, such as:
- Measured molecular mass
- Chromatographic purity
- Water content
- Residual solvent
- Counterion content
- Appearance
- Solubility information
- Storage recommendation
- Analytical method
- Batch release date
Give each document a stable file name. For example:
P17_LotA32_CertificateOfAnalysis_20260802.pdf
Avoid names such as new.pdf, final document.pdf, or peptide data latest.pdf. These names become confusing after several months.
The ICH M10 guideline recommends that critical reagent records include identity, source, lot number, purity where relevant, concentration where relevant, stability information, and storage conditions. Although ICH M10 mainly applies to bioanalytical work supporting regulatory decisions, these fields are also useful in ordinary research laboratories.
4. Document Receipt and Storage
When a peptide arrives, record its condition.
Was the package cold? Was the vial sealed? Was the material lyophilized? Did the shipment arrive late? Was there visible moisture or damage?
Record the date and time of receipt, the person who received it, the condition of the package, and the storage location.
A storage record should include:
- Freezer or refrigerator identification
- Shelf, rack, box, and position
- Target storage temperature
- Actual temperature monitoring system
- Protection from light or moisture
- Date placed into storage
- Date removed
- Time outside controlled storage
- Any temperature excursion
- Final disposal date
Do not copy a general storage temperature from another peptide. Storage requirements can depend on the exact material and formulation.
For example, one NIST peptide reference material was supplied in sealed amber glass vials with specific instructions for storage with desiccant at minus 20 degrees Celsius. Those conditions belonged to that material and should not be treated as a universal rule for all peptides.
Follow the supplier instructions unless your laboratory has generated stability data that supports another condition.
5. Record Reconstitution in Full
Reconstitution is one of the most important stages in a peptide experiment. A small mistake here can affect every sample that follows.
Record:
- Date and time of reconstitution
- Researcher name
- Peptide lot number
- Amount of material used
- Whether the amount refers to total powder or net peptide
- Solvent identity
- Solvent lot number
- Solvent grade
- Solvent volume
- Target concentration
- Calculation used
- Mixing method
- Mixing time
- Solution appearance
- Observed particles or cloudiness
- Measured pH, when relevant
- Final container type
- Final storage condition
- Assigned solution identification code
Do not write only “dissolved according to protocol.” A protocol may describe the general method, but the experiment record must show what actually happened.
Save the concentration calculation. If peptide content is less than the total powder mass, the difference can affect the final concentration.
For example, suppose a vial contains 1 milligram of total material, but its documented peptide content is 0.72 milligram. Preparing the solution as though the full milligram were active peptide would overstate the concentration.
That error would then flow through the experiment like a wrong number entered at the top of a spreadsheet.
6. Use an Aliquot and Freeze Thaw Log
When possible, plan aliquots before preparing the stock solution.
Each aliquot should have a unique code connected to the parent stock. Record the aliquot volume, concentration, container type, preparation date, storage location, and intended use.
A simple relationship may look like this:
Parent stock: P17_STK01
Aliquots: P17_STK01_A01, P17_STK01_A02, and P17_STK01_A03
Each time an aliquot is removed, record the date, time, purpose, thawing condition, and whether any material was returned to storage.
Why does this matter? Repeated freezing and thawing may affect some analytes. The effect must be studied under conditions that match the real experiment rather than assumed from unrelated literature.
ICH M10 states that stability studies should reflect the actual sample matrix, container, time, temperature, and handling conditions. For regulated bioanalysis, the validated number of freeze thaw cycles should equal or exceed the number experienced by study samples.
An exploratory academic project may not need full regulatory validation. It should still record the number of freeze thaw events so later changes can be investigated.
7. Write the Method So Another Researcher Can Repeat It
A method should work like a map. A reader should not need to guess where to turn.
Record the exact order of operations. Include quantities, times, temperatures, mixing settings, incubation conditions, plate types, instruments, and decision rules.
For a cell based peptide assay, the method may need to include:
- Cell source
- Cell line or donor code
- Passage number
- Culture medium
- Supplement details
- Seeding density
- Plate format
- Time between seeding and treatment
- Peptide concentration range
- Treatment volume
- Vehicle concentration
- Exposure duration
- Incubator conditions
- Sample collection method
- Readout method
- Normalisation method
- Exclusion criteria
- Data analysis plan
For an LC MS experiment, record the sample preparation method, column details, mobile phases, gradient, flow rate, injection volume, source settings, acquisition method, processing method, calibration status, and instrument identification.
HUPO Proteomics Standards Initiative resources provide reporting guidance and data standards for mass spectrometry, quantitative proteomics, quality control information, and peptide related annotations. These standards support more consistent exchange and interpretation of proteomics data.
8. Record Every Reagent and Critical Material
Peptide experiments rarely depend on the peptide alone.
Buffers, enzymes, antibodies, matrices, culture media, standards, internal standards, plates, tubes, and extraction materials can influence the result.
For every critical reagent, record:
- Name
- Manufacturer
- Catalogue number
- Lot number
- Concentration
- Preparation date
- Expiry date
- Storage condition
- Person who prepared it
- Link to the preparation record
Lot numbers matter because two lots of the same product may not perform in exactly the same way. When a result changes after a lot change, documentation allows the team to see the connection.
Do not silently replace a reagent. Record the reason, date, comparison testing, and approval where required.
9. Define Controls Before the Experiment
Controls are the ruler used to judge the experiment. Without them, a result may look meaningful even when the method has failed.
Depending on the study, controls may include:
- Untreated control
- Vehicle control
- Positive control
- Negative control
- Blank matrix
- Process blank
- Calibration standard
- Quality control sample
- Internal standard
- Reference peptide
- No enzyme control
- No primary antibody control
Document how every control was prepared. Also define the acceptance rules before viewing the final result.
For example, state that the positive control must produce a response within an established range. If it falls outside that range, record whether the entire run will be rejected or investigated.
In regulated bioanalysis, ICH M10 expects analytical run acceptance and rejection criteria to be defined in a protocol, study plan, or standard operating procedure.
An academic laboratory can apply the same basic logic on a smaller scale. Decide what counts as a valid run before seeing whether the result supports the hypothesis.
10. Keep Raw Data and Metadata Together
Raw data are not limited to final spreadsheets.
They may include instrument files, chromatograms, spectra, plate reader outputs, photographs, microscopy files, balance records, temperature logs, handwritten observations, and automated system records.
Metadata explain those data. A measurement of “12.4” means little without the sample identity, unit, time, method, instrument, and processing history.
OECD guidance explains that data may exist on paper, in electronic systems, in images, in instrument records, or across hybrid systems. Raw data and related metadata should allow an activity to be reconstructed and evaluated.
Store the following together or connect them through clear links:
- Raw instrument file
- Sample map
- Instrument method
- Processing method
- Calibration information
- Researcher notebook entry
- Derived result file
- Statistical analysis file
- Figure used in the report
- Final interpretation
Never keep only a screenshot of a graph when the original instrument file exists. A screenshot may hide acquisition settings, integration history, excluded points, or audit information.
11. Protect Original Data During Analysis
Analysis should create new files rather than replace the originals.
Use a simple folder structure such as:
01_Protocol
02_PeptideRecords
03_RawData
04_ProcessedData
05_Analysis
06_Figures
07_Reports
Set the raw data folder to read only when possible. Place calculations and processed results in separate folders.
Record:
- Software name
- Software version
- Processing method version
- Analysis date
- Researcher name
- Statistical test
- Data transformation
- Normalisation method
- Excluded values
- Reason for every exclusion
- Script or formula used
- Random seed, when relevant
- Output file name
- Link to the source data
FAIR data principles encourage research data and workflows to be findable, accessible under suitable conditions, interoperable, and reusable. FAIR does not mean that every file must be public. It means that data should be organised and described well enough to be found and understood by authorised users.
12. Document Manual Changes and Reintegration
Manual changes deserve special attention.
Suppose a researcher adjusts the baseline of a chromatogram or reintegrates a peak. The revised result may be scientifically justified, but the original result must remain available.
Record:
- Original result
- Revised result
- Person making the change
- Date and time
- Reason for the change
- Method used
- Reviewer approval, when required
- Effect on the reported conclusion
ICH M10 recommends keeping original and reintegrated chromatograms, recording the reason for reintegration, and reporting departures from the planned integration procedure.
The same principle applies to microscopy thresholds, background subtraction, curve fitting, outlier removal, and manual correction of sample labels.
A hidden correction weakens trust. A visible correction with a sound reason strengthens it.
13. Record Deviations, Failures, and Unexpected Events
A good notebook is not a success diary. It is a truthful record.
Record failed runs, spilled samples, incorrect temperatures, instrument alarms, missing wells, cloudy solutions, power loss, delayed processing, calculation errors, and unexpected observations.
A deviation record should answer:
- What happened?
- When did it happen?
- Who discovered it?
- Which samples were affected?
- What was the likely cause?
- What immediate action was taken?
- Was the data retained, rejected, or repeated?
- Who reviewed the decision?
- What will prevent the problem from happening again?
Do not delete an unsuccessful run simply because a later run worked. Failed data may reveal instability, carryover, adsorption, instrument drift, contamination, or operator error.
OECD GLP data integrity guidance expects records to remain complete, consistent, accurate, and capable of supporting reconstruction of the work. It also places responsibility on study personnel to record raw data promptly and accurately.
14. Apply the ALCOA Plus Principles
ALCOA Plus provides a useful test for laboratory records.
Attributable
The record shows who performed the work and who made each change.
Legible
The information can be read and understood.
Contemporaneous
The activity is recorded when it happens, not reconstructed several days later.
Original
The first record or a verified copy is preserved.
Accurate
The record reflects what actually happened.
Complete
Successful, unsuccessful, repeated, and excluded results are retained.
Consistent
Dates, times, sample codes, and steps follow a logical order.
Enduring
The record remains usable throughout the required retention period.
Available
Authorised users can retrieve the information when needed.
MHRA guidance describes ALCOA Plus as attributable, legible, contemporaneous, original, accurate, complete, consistent, enduring, and available throughout the data life cycle.
These principles were developed for regulated environments, but they also provide a clear quality check for academic research.
15. Choose Paper or Electronic Records Carefully
Both paper notebooks and electronic laboratory notebooks can work well. Both can also fail when used poorly.
A paper notebook offers a simple chronological record. However, instrument files, large datasets, images, and analysis scripts usually remain electronic.
An electronic laboratory notebook can connect protocols, samples, files, and results. It may also provide search tools, access controls, time stamps, version history, and audit trails.
The best choice depends on the research environment. Whatever system you use, define:
- Who can create records
- Who can edit records
- How changes are tracked
- How records are reviewed
- How backups are made
- How access is removed when staff leave
- How files are exported
- How long records are retained
- How the system will be recovered after failure
- Who owns the data
Electronic records should not depend on one researcher’s personal laptop, personal cloud account, or removable drive.
FDA data integrity guidance explains that integrity must be protected throughout the data life cycle, including creation, modification, processing, maintenance, archival, retrieval, transmission, and final disposition.
16. Use Consistent Sample Names
A strong sample name communicates meaning without becoming too long.
A useful format might include:
Project_Peptide_Batch_Group_Time_Replicate
For example:
PX42_P17_LotA32_Treated_24h_R03
Create a naming guide before the study starts. Define every abbreviation and use it across notebooks, tubes, plates, instruments, spreadsheets, and reports.
Do not allow one sample to have five unrelated names.
A sample called Tube 7 in the notebook, Test B on the instrument, and Final Sample 3 in the spreadsheet is an invitation to confusion.
Barcodes can reduce manual entry errors, but they do not replace readable identifiers. A person should still be able to understand the basic sample identity when the scanner is unavailable.
17. Review the Record Before Closing the Experiment
Do not wait until manuscript preparation to discover missing information.
At the end of the experiment, perform a record review. Confirm that:
- All samples can be traced to their source
- All peptide lots are identified
- Reconstitution calculations are present
- Storage and thaw records are complete
- Reagent lots are recorded
- Instrument files are saved
- Controls met the planned criteria
- Deviations are explained
- Exclusions have reasons
- Analysis files connect to raw data
- Figures match the reported results
- The final conclusion matches the evidence
- A second person has reviewed critical records
- Required backups have completed
- The experiment status is marked as complete
This review is like checking a parachute before jumping. It is much easier to correct a missing label today than six months later.
18. Understand the Difference Between Academic and Regulated Work
Not every peptide experiment must follow full GLP, GCP, GMP, or ICH requirements.
ICH M10 mainly covers bioanalytical methods used to support regulatory decisions in drug development. It also notes that exploratory studies outside regulatory decision making may use a level of qualification suited to their internal purpose.
An early university project may use a shorter documentation system. A study supporting a clinical trial, safety assessment, or regulatory submission will require much stronger controls, formal validation, approved procedures, quality assurance, and controlled archives.
The level of documentation should match the risk and intended use of the data. However, the basic expectations remain similar: identify the material, describe the method, preserve the data, explain changes, and make the work understandable.
19. Prepare Data for Sharing and Future Reuse
Research records should serve the future, not only the present experiment.
NIH policy expects covered research projects to plan how scientific data and related metadata will be managed, preserved, and shared. The NIH Data Management and Sharing Policy has been effective since January 25, 2023, and the policy remained in place in 2026.
Before archiving a peptide dataset, include:
- A clear readme file
- A data dictionary
- Units for every variable
- Sample code definitions
- Peptide identity information
- Method version
- Software information
- Quality control results
- Exclusion rules
- File relationships
- Access restrictions
- Ethical or privacy limits
- Licence information, when shared
- Contact information for the dataset owner
Imagine that a new researcher opens the folder three years from now. Can that person understand the experiment without calling the original researcher?
That is a useful test of documentation quality.
Practical Peptide Experiment Record Template
A complete record can follow this order:
Section 1: Experiment Overview
Record the experiment code, title, question, hypothesis, researcher, dates, protocol version, and planned outcomes.
Section 2: Peptide Identity
Record the sequence, modifications, supplier, lot, molecular mass, purity information, net content, certificate location, and expiry date.
Section 3: Storage History
Record the receipt condition, storage location, temperature, light protection, moisture control, temperature events, and removal history.
Section 4: Solution Preparation
Record the peptide amount, correction for content, solvent, volume, concentration, calculation, appearance, pH, mixing method, and preparation time.
Section 5: Aliquot History
Record each aliquot code, volume, container, storage location, thaw count, use date, remaining volume, and disposal.
Section 6: Experimental Method
Record the procedure, sample order, instruments, settings, times, temperatures, reagents, plates, tubes, and operator observations.
Section 7: Controls and Acceptance Rules
Record all controls, expected ranges, calibration details, quality control samples, and rules for accepting or rejecting the run.
Section 8: Raw Data
Link the notebook entry to instrument files, images, sample maps, logs, and original observations.
Section 9: Data Processing
Record software, versions, scripts, formulas, normalisation, transformations, exclusions, reintegration, and statistical analysis.
Section 10: Deviations
Describe every departure from the plan, its effect, investigation, decision, and corrective action.
Section 11: Results and Interpretation
Summarise the results without hiding negative or conflicting findings. Separate direct observations from interpretation.
Section 12: Review and Approval
Record the reviewer, review date, unresolved questions, final status, backup confirmation, and archive location.
Common Documentation Mistakes to Avoid
The most common problem is not a complete absence of records. It is incomplete connection between records.
A notebook may contain the method, while the peptide lot appears in an email, the sample map sits beside the instrument, and the final calculations live on a personal computer.
Other common mistakes include:
- Recording only the peptide name without its sequence
- Confusing chromatographic purity with peptide content
- Failing to record the counterion or modification
- Preparing solutions without saving calculations
- Reusing aliquots without tracking thaw events
- Writing records several days after the experiment
- Overwriting raw data
- Keeping only exported graphs
- Changing sample names during analysis
- Excluding results without a written reason
- Repeating a failed assay without recording the first run
- Using an updated protocol without noting the version
- Failing to save software settings
- Storing data in personal accounts
- Reporting more certainty than the records support
The solution is not endless paperwork. The solution is a connected record in which each decision, sample, file, and result has a clear place.
Conclusion
Good documentation turns a peptide experiment from a private laboratory event into reliable scientific evidence. It begins with a clear question, follows the peptide from receipt to final analysis, preserves original data, and explains every important decision. The strongest record does not pretend that the experiment was perfect. It shows what was planned, what actually happened, what changed, and how the researchers reached their conclusion. When another trained person can reconstruct the work without guessing, the documentation has done its job.
Frequently Asked Questions
What information should be written on a peptide aliquot label?
The label should include a unique aliquot code, peptide identity, concentration, preparation date, and storage condition. The electronic or paper record should connect that code to the peptide sequence, lot number, solvent, volume, and parent stock.
Is the purity percentage on a certificate enough to calculate peptide concentration?
Not always. The stated purity may refer to chromatographic area rather than the actual mass of peptide in the vial. Check whether the certificate provides net peptide content, water content, counterion content, or another value needed for concentration calculations.
Should failed peptide experiments be kept?
Yes. Failed experiments may reveal problems with stability, concentration, adsorption, contamination, instruments, reagents, or sample handling. Record the failure, investigation, and decision rather than deleting the data.
How often should a peptide stock solution be frozen and thawed?
There is no universal number for every peptide. Follow material specific instructions or stability data. Record every thaw event and design aliquots to reduce unnecessary reuse.
Can a researcher write notebook entries at the end of the week?
This practice should be avoided. Records are more reliable when written at the time of the activity. Delayed entries can miss exact times, observations, volumes, mistakes, and unexpected events.
What is the difference between raw data and processed data?
Raw data are the original observations or instrument outputs. Processed data are created through steps such as integration, background correction, normalisation, calculation, or statistical analysis. Both should be retained and connected.
Should screenshots of chromatograms be stored?
Screenshots can support a record, but they should not replace original instrument files. Original files may contain acquisition settings, metadata, audit history, integration details, and other information that a screenshot cannot show.
What should happen when a peptide supplier changes the lot number?
Record the new lot and compare critical properties such as identity, purity, content, solubility, and assay performance. The amount of comparison testing should match the importance of the peptide to the experiment.
Does every peptide experiment need to follow GLP?
No. GLP applies to defined types of regulated studies. Exploratory academic work may use a simpler system. However, principles such as traceability, timely recording, preservation of raw data, and clear explanations remain valuable in every laboratory.
How long should peptide experiment records be retained?
The retention period depends on institutional policy, funding conditions, publication rules, intellectual property needs, ethics requirements, and applicable regulations. The laboratory should define the period before records are archived or destroyed.
Can an Excel spreadsheet be used as a laboratory record?
A spreadsheet can be part of the record, but it should not stand alone without controls. Keep the source data, formulas, version history, file owner, dates, units, and explanation of changes. Protect the original file from accidental overwriting.
What is the simplest test of good peptide documentation?
Ask a trained colleague who did not perform the experiment to reconstruct it. When that person can identify the peptide, repeat the method, locate the raw data, understand the calculations, and explain the final decision without guessing, the documentation is working.




